Robert W Fairbairn sold $308K of BlackRock Health Sciences Term (BMEZ)

Executed Dec 18 2025, disclosed Dec 22 2025, 4 days later.

Value, as filed

$308K

20,588 sh across 2 lots

Executed

Dec 18 2025

the trade date, as filed

Disclosed

Dec 22 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RF Robert W Fairbairn Director profile →

Robert W Fairbairn (Director) filed 4 Form 4 reports in the trailing twelve months (1 purchase, 3 sales), most often in BMEZ. Across 1 priced purchase filing, the average 21-session return was -4.5% from execution and -4.5% from disclosure (delay-adjusted; derived). The largest single filing was $498K of MYN (49,025 sh × $10.15, as filed), executed Feb 27.

The name

BMEZ BMEZ BMEZ · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→